Department Of Urology 2

51. Sharing surgical images on social media: a snapshot of practices and some reflections for improvement
52. Social media and urology: The good, the bad and the ugly
53. Social media and urology: The good, the bad and the ugly
54. Social media and urology: The good, the bad and the ugly
55. Social media and urology: The good, the bad and the ugly
56. Social media and urology: The good, the bad and the ugly
57. Social media and urology: The good, the bad and the ugly
58. Social media and urology: The good, the bad and the ugly
59. Social media and urology: The good, the bad and the ugly
60. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
61. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
62. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
63. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
64. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
65. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
66. The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia
67. RISK ASSESSMENT SCALE FOR THE DEVELOPMENT OF ACUTE PYELONEPHRITIS IN WOMEN AT DIFFERENT STAGES OF PREGNANCY
68. RENAL AUTOTRANSPLANT AS A TREATMENT METHOD IN A PATIENT WITH URETERAL STRICTURE: A CASE REPORT
69. Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?
70. Applications used to minimize forgotten stents: a systematic review of the literature. Is it the dawn of a new era?
71. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
72. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
73. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
74. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
75. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
76. An observational 3-year follow-up study for postoperative renal function changes assessed by ^{99 m}Tc-DTPA scintigraphy and predictive factors after miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery
77. Nanotherapeutic formulations of enzyme inhibitors targeting cancer and neuroinflammation: An updated review
78. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
79. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
80. Revolutionizing Organ Donation With Blockchain Technology: Prospects and Challenges In Healthcare
81. Revolutionizing Organ Donation With Blockchain Technology: Prospects and Challenges In Healthcare
82. Revolutionizing Organ Donation With Blockchain Technology: Prospects and Challenges In Healthcare
83. Revolutionizing Organ Donation With Blockchain Technology: Prospects and Challenges In Healthcare
84. Revolutionizing Organ Donation With Blockchain Technology: Prospects and Challenges In Healthcare
85. Digital health innovations in urology: Telemedicine, wearables, and mobile applications - A systematic review of literature
86. Digital health innovations in urology: Telemedicine, wearables, and mobile applications - A systematic review of literature
87. Digital health innovations in urology: Telemedicine, wearables, and mobile applications - A systematic review of literature
88. Smart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
89. Smart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
90. Smart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
91. Efficacy and Safety of Intracavernous Administration of Platelet-Rich Plasma in the Treatment of Erectile Dysfunction in Kazakh Population: Results of a Six-Month Follow-Up
92. Patient consent in the modern era: Novel tools and practical considerations in urology
93. Patient consent in the modern era: Novel tools and practical considerations in urology
94. Patient consent in the modern era: Novel tools and practical considerations in urology
95. Patient consent in the modern era: Novel tools and practical considerations in urology
96. Patient consent in the modern era: Novel tools and practical considerations in urology
97. Patient consent in the modern era: Novel tools and practical considerations in urology
98. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
99. Innovative Strategies in Lean Supply Chain Management: Enhancing Efficiency in Healthcare
100. Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature
1 2 3 4 8